






Sn¼156). Red cell distribution width (RDW), neutrophile-lymphocyte ratio (NLR) and
peak high sensitive C-reactive protein (hs-CRP) levels were measured. We also
evaluated in hospital clinical course of the patients.
Results: RDW, NLR and peak hs-CRP levels were signiﬁcantly lower in patients with
lead endocarditis when compared with non-lead endocarditis (14,8  1,6 versus 16,7
 3,1, p¼0,01, 2,9  1,07 versus 7,4  7, p¼0,01 and 22,4  31,3 versus 58,6  69,
p¼0,03 respectively). In hospital mortality was similar in two groups (11.7% versus
30.1%, p¼0.11). Ejection fraction was lower in the group with lead endocarditis
(49,7% 14,4 versus 55,6%  9.8, p¼0.03) however, clinical congestive heart failure
was more common in the non-lead endocarditis group (28,2% versus 5,8%, p¼0.004).
Conclusıon: In hospital mortality was similar in patients with lead and non-lead left
sided endocarditis. Inﬂammatory markers such as RDW, NLR and hs-CRP were lower
in lead endocarditis. Additionally despite of lower ejection, clinical congestive heart
failure development was less in lead endocarditis which all should alert physicians that
lead endocarditis might have more silent course and might be omitted.
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Introductıon: After its introduction by Jatene and colleagues in 1975, the arterial
switch operation (ASO) has become the surgical technique of choice for correction of
transposition of the great arteries (TGA) with or without ventricular septal defect
(VSD). Short- and mid-term results are promising, but data on long-term outcome are
limited and major complications may occur.
Objectıves: Our work is intended to assess the long term results of ASO in Tunisian
children with TGA and to identify potential factors affecting these results.
Methods: We studied 44 patients with ASO (mean age: 11.5 years, 73%-male, 50 %
TGA with VSD) followed at our department. The inclusion criterion was at least 5
years of follow-up. Complete clinical examination, standard and 24-hour Holter
electrocardiogram, M-mode, 2D-and color Doppler echocardiography and coronary
investigations were performed.
Results: Mean follow-up was 106 months (8.83 years). One patient died (2.27%).
Impaired left ventricular function was observed in 5 cases (11.36%). Right ventricular
outﬂow tract obstruction was observed in 6 patients (13.63%) requiring reintervention
in 2 cases. Pulmonary regurgitation was frequent (40.90%). Aortic regurgitation was
observed in 20 patients (45.45%) but appeared not to be progressive. Coronary lesions
were found in 4 patients (9.09%) requiring a coronary artery bypass graft (CABG) in 1
case. Intramural coronary artery course was the risk factor of late coronary arteries
lesions (p¼0.013) Freedom from late reintervention was 84% at 15 years after ASO.
Eight late reinterventions were performed in 4 patients (9.09%) with a mean age of
10.43 years.
Conclusıon: The TGA, including complex types, can be corrected with good long-
term outcomes by ASO. The association to a VSD was not considered to be
a predictor of long-term complications except of aortic regurgitation. Right ventricular
outﬂow tract dysfunction was the main reason for late reinterventions. Potential risk of
myocardial ischemia requires regular appropriate follow up.
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Background: Low HDL cholesterol (HDL-C) levels are now recognized as an
independent cardiovascular risk factor and comprise part of the metabolic syndrome.
Low testosterone (T) levels are a common ﬁnding in men with coronary artery disease.
Methods: The relationship between endogenous plasma testosterone and high-density
lipoprotein cholesterol (HDL-C) was assessed among 933 men (27-74) years old
originally recruited for an cross-sectional study of endogenous testosterone and
coronary artery disease (CAD). Patients underwent coronarygraphy and at the same
time, serial testosterone was measured, triglycerides, total-and HDL-cholesterol.
Results: Patients (coronary narrowing >50% n ¼ 689) were compared to those
without signiﬁcant stenoses (n ¼ 244). High-density lipoprotein cholesterol (HDLC)
and triglyceride were both signiﬁcantly associated with the presence of CAD
(p<0.05). Testosterone (mean 5.5682.109 nmol/l range 0.106 – 14.108 nmol/l)JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTcorrelated directly with HDL-cholesterol (r¼0. 0.358, < P¼0.0500) and inversely
with triglycerides (r¼-0.069, p<0.0010),but not with LDL-cholesterol (r¼0.140,
p¼0.1990) total cholesterol (r¼-0.036, p<0.820),
Conclusıons: These ﬁndings suggest the positive association between levels of
testosterone and HDL cholesterol, The negative association between levels of
testosterone triglyceride.
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Background: Low circulating levels of high density lipoprotein-cholesterol (HDL-C)
is the most common form of dyslipidemia in coronary heart disease (CHD). In
previous studies, it has been shown that low circulating levels of HDL-C is a strong,
independent risk factor for premature atherosclerosis and CHD. Plasma HDL-C
particles exert potent anti-atherogenic and anti-inﬂammatory activities in addition to
antioxidant activity. Thus, we aimed to investigate biochemical parameters associated
with oxidative stress stress in low HDL-C.
Method: This study included 33 consecutive patients with low HDL-C (35 mg/dl)
(18 male, age 5513 years) and 33 age and sex-matched control subjects with normal
HDL-C (>35 mg/dl) (17 male, mean age 5813 years). We evaluated clinical
parameters and laboratory parameters which are associated with oxidative stress such as
total oxidative status (TOS), total antioxidant capacity (TAC), oxidative stress index
(OSI), uric asit, gamma glutamyl transferase (GGT) and alkaline phosphatase (ALP).
Results: Groups were comparable in demographic and clinic characteristics. Except
for ALT levels routine laboratory tests were similar in both groups. ALT levels was
higher in low HDL-C patients than in subjects with normal HDL-C (2919 vs 185.3
mg/dl, p<0.01). Triglyceride (TG) levels were higher in low HDL-C group, total
cholesterol (TK) and low density lipoprotein (LDL) levels were signiﬁcantly higher in
control group. HDL-C levels was lower in patients group than in control group (303
vs 487 mg/dl, p<0.01). Uric asit (6.31.5 vs 4.51.3, respectively p<0.01) and
GGT levels [35 (10-122) vs 23 (11-71.6), p¼0.02] were signiﬁcantly higher in low
HDL-C group than in control group. TOS levels were signiﬁcantly higher in low
HDL-C group than in control group [2.95 (0.01-7.26) vs 1.17 (0.80-1.80), p<0.01],
TAC levels were signiﬁcantly lower in low HDL-C group than in control group [1.15
(0.08-2.25) vs 1.99 (0.42-6.21), p<0.01]. OSI levels [474 (1.19-5050) vs 176 (28-
597), p¼0.06] were slightly higher in HDL-C group although it is not signiﬁcant.
Conclusıon: Our ﬁndings show that oxidative stress levels increase in patients with low
HDL-C. From this aspect, treatments that increase HDL levels or improve the antioxi-
dant status in low HDL-C patients might be reasonable to slow down the process of
oxidative stress. However, this result needs to be validated in large-sized studies.
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Purpose: Catestatin (CST), a novel peptide derived from Chromogranin A, has
diverse cardiovascular actions in addition to diminished sympathoadrenal ﬂow. We
intended to investigate metabolic and vascular associations of CST.
Methods: We evaluated plasma catestatin, lipid parameters, left ventricular mass,
carotid intima-media thickness (CIMT) and ﬂow-mediated dilation (FMD) of brachial
artery in a group of 109 consecutive untreated hypertensive patients.
Results: Catestatin levels were signiﬁcantly higher in females. Among all study
parameters age (r¼0.280, p¼0.001), high density lipoprotein (HDL) (r¼0.426,
p<0.001) positively whereas triglycerides (r¼-0.317, p¼0.002), hemoglobin (r¼-
0.273, p¼0.010), and left ventricular mass (r¼-0.230, p¼0.034) negatively correlated
to plasma catestatin. We could not detect an association between vascular parameters
and catestatin. We also documented increased CST concentrations in previously
untreated hypertensive patients compared to healthy controls (2.27 vs. 1.92 ng/ml,
p¼0.004). Multiple linear regression analysis revealed age (Beta: 0.201, p¼0.041) and
HDL cholesterol (Beta: 0.390, p<0.001) as independent correlates of plasma cate-
statin concentration.
Conclusıon:We documented that catestatin is correlated with high density lipoprotein
concentrations among several metabolic, vascular and biochemical parameters, in
previously untreated hypertensive patients. The physiology and clinical signiﬁcance of
this association remains unknown and requires further studies to be identiﬁed.ERS C181
